Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H GOLDIE

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Biochemical Pharmacology|April 1, 1986
Further studies on substituted quinazolines and triazines as inhibitors of a methotrexate-insensitive murine dihydrofolate reductaseS Dedhar, J H Freisheim, J B Hynes, et al.
Journal of Neurosurgery|October 1, 1996
Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytomaW W Jia, J Tan, G J Redekop, et al.
Biochemical Pharmacology|March 1, 1983
Inhibition of a methotrexate-insensitive dihydrofolate reductase from L5178Y cells by substituted triazines and quinazolinesS Dedhar, J H Freisheim, J B Hynes, et al.
Leukemia & Lymphoma|August 1, 2002
A literature review of single agent treatment of multiply relapsed aggressive non-Hodgkin's lymphomaMurray S Webb, David L Saltman, Joseph M Connors, et al.
Leukemia & Lymphoma|August 1, 1997
The use of conventional salvage chemotherapy before dose-intensive cytotoxic therapy and autologous transplantation for aggressive-histology lymphoma: a case for re-evaluationG L Phillips, D E Reece, S N Wolff, et al.
Nature Structural Biology|April 1, 1996
Snapshot of an enzyme reaction intermediate in the structure of the ATP-Mg2+-oxalate ternary complex of Escherichia coli PEP carboxykinaseL W Tari, A Matte, U Pugazhenthi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patientsS Dedhar, D Hartley, D Fitz-Gibbons, et al.
European Journal of Biochemistry|August 26, 1998
Stability of Escherichia coli phosphoenolpyruvate carboxykinase against urea-induced unfolding and ligand effectsM V Encinas, J A Evangelio, J M Andreu, et al.
Biochimica Et Biophysica Acta|February 8, 1997
Identification of reactive conserved histidines in phosphoenolpyruvate carboxykinases from Escherichia coli and Saccharomyces cerevisiaeS Bazaes, L Montecinos, H Krautwurst, et al.
Journal of Protein Chemistry|July 1, 1996
Woodward's reagent K reacts with histidine and cysteine residues in Escherichia coli and Saccharomyces cerevisiae phosphoenolpyruvate carboxykinasesP Bustos, M I Gajardo, C Gómez, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Biochemical Pharmacology|April 1, 1986
Further studies on substituted quinazolines and triazines as inhibitors of a methotrexate-insensitive murine dihydrofolate reductaseS Dedhar, J H Freisheim, J B Hynes, et al.
Journal of Neurosurgery|October 1, 1996
Toxicity studies in thymidine kinase-deficient herpes simplex virus therapy for malignant astrocytomaW W Jia, J Tan, G J Redekop, et al.
Biochemical Pharmacology|March 1, 1983
Inhibition of a methotrexate-insensitive dihydrofolate reductase from L5178Y cells by substituted triazines and quinazolinesS Dedhar, J H Freisheim, J B Hynes, et al.
Leukemia & Lymphoma|August 1, 2002
A literature review of single agent treatment of multiply relapsed aggressive non-Hodgkin's lymphomaMurray S Webb, David L Saltman, Joseph M Connors, et al.
Leukemia & Lymphoma|August 1, 1997
The use of conventional salvage chemotherapy before dose-intensive cytotoxic therapy and autologous transplantation for aggressive-histology lymphoma: a case for re-evaluationG L Phillips, D E Reece, S N Wolff, et al.
Nature Structural Biology|April 1, 1996
Snapshot of an enzyme reaction intermediate in the structure of the ATP-Mg2+-oxalate ternary complex of Escherichia coli PEP carboxykinaseL W Tari, A Matte, U Pugazhenthi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1985
Heterogeneity in the specific activity and methotrexate sensitivity of dihydrofolate reductase from blast cells of acute myelogenous leukemia patientsS Dedhar, D Hartley, D Fitz-Gibbons, et al.
European Journal of Biochemistry|August 26, 1998
Stability of Escherichia coli phosphoenolpyruvate carboxykinase against urea-induced unfolding and ligand effectsM V Encinas, J A Evangelio, J M Andreu, et al.
Biochimica Et Biophysica Acta|February 8, 1997
Identification of reactive conserved histidines in phosphoenolpyruvate carboxykinases from Escherichia coli and Saccharomyces cerevisiaeS Bazaes, L Montecinos, H Krautwurst, et al.
Journal of Protein Chemistry|July 1, 1996
Woodward's reagent K reacts with histidine and cysteine residues in Escherichia coli and Saccharomyces cerevisiae phosphoenolpyruvate carboxykinasesP Bustos, M I Gajardo, C Gómez, et al.
Pageof 6